← Open Payments lookup

TRI NGUYEN: Open Payments

NPI 1427155829 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,603 in 117 payments from 29 companies in 2025. Trend: 2023 $2,434 · 2024 $2,876 · 2025 $2,603

Food & beverage: $2,603
CompanyPaymentsAmount
PFIZER INC.12$263
Cleerly, Inc.3$239
Amgen Inc.14$207
Novo Nordisk Inc12$186
AstraZeneca Pharmaceuticals LP3$168
ViiV Healthcare Company6$155
Axsome Therapeutics, Inc.7$155
ABBVIE INC.9$148
Otsuka America Pharmaceutical, Inc.8$146
ABIOMED3$113

Products named: Cleerly Ischemia, ELIQUIS, APRETUDE, REXULTI, AIRSUPRA, Auvelity, EVENITY, Wegovy.

Industry payments across TX — which companies pay providers there.